Earnings Call Overview: Xponential Fitness held its Q2 2025 earnings conference call on August 7, 2025, featuring key executives including CEO Mike Nuzzo and CFO John Meloun, discussing financial results and future projections.
Forward-Looking Statements: The company emphasized that the call included forward-looking statements regarding business outlook and financial projections, which are subject to risks and uncertainties that may affect actual outcomes.
XPOF
$7.43+Infinity%1D
Analyst Views on XPOF
Wall Street analysts forecast XPOF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XPOF is 9.86 USD with a low forecast of 8.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast XPOF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XPOF is 9.86 USD with a low forecast of 8.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
5 Hold
0 Sell
Moderate Buy
Current: 7.290
Low
8.00
Averages
9.86
High
13.00
Current: 7.290
Low
8.00
Averages
9.86
High
13.00
Stifel
Chris O'Cull
Hold
downgrade
$10 -> $8
2025-11-21
Reason
Stifel
Chris O'Cull
Price Target
$10 -> $8
2025-11-21
downgrade
Hold
Reason
Stifel analyst Chris O'Cull lowered the firm's price target on Xponential Fitness to $8 from $10 and keeps a Hold rating on the shares. The firm, which is revising estimates to account for continued operational headwinds following the company's latest 10-Q filing, notes that its FY26 projection now assumes an elevated rate of studio closures and that it reduced its FY26 EBITDA estimate to about $110M.
Guggenheim
Buy
downgrade
$13 -> $12
2025-11-10
Reason
Guggenheim
Price Target
$13 -> $12
2025-11-10
downgrade
Buy
Reason
Guggenheim lowered the firm's price target on Xponential Fitness to $12 from $13 and keeps a Buy rating on the shares. The business "remains in refinement mode," but the firm sees shares as undervalued, especially given Club Pilates' "increasingly dominant contribution," the analyst tells investors.
Baird
Neutral
downgrade
$9 -> $8
2025-11-07
Reason
Baird
Price Target
$9 -> $8
2025-11-07
downgrade
Neutral
Reason
Baird lowered the firm's price target on Xponential Fitness to $8 from $9 and keeps a Neutral rating on the shares. The firm updated its model following Q3 results where the company is still navigating a range of challenges.
B. Riley
Neutral
downgrade
$9 -> $8
2025-11-07
Reason
B. Riley
Price Target
$9 -> $8
2025-11-07
downgrade
Neutral
Reason
B. Riley lowered the firm's price target on Xponential Fitness to $8 from $9 and keeps a Neutral rating on the shares.
About XPOF
Xponential Fitness, Inc. is a global franchisor of boutique health and wellness brands. The Company operates a diversified platform of six brands spanning modalities including Pilates, barre, stretching, strength training and yoga. In partnership with its franchisees, it offers a personalized workout experience in studio locations throughout the United States and internationally, with franchise, master franchise and international expansion agreements. The Company’s portfolio of brands includes Club Pilates, the Pilates brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; YogaSix, the franchised yoga brand in the United States; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements, and the Barre brand in the United States; BFT, a functional training and strength-based program.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
